journal article·2022-10-28Open access

Extremely Small Iron Oxide Nanoparticles with pH-Dependent Solubility Transition as T1/T2 Switchable Contrast Agents for MRI

Yilin He, Zheng Mao, Zhongzhong Lu, Jincong Yan, Ye Zhang, Alberto Bianco, Yi Cao, Renjun Pei

ACS Applied Nano Materials· Volume 5· Issue 10

Abstract

Extremely small iron oxide nanoparticles (ESIONPs), which have a switchable contrast signal and a favorable biocompatibility, are gaining considerable attention as smart magnetic resonance imaging (MRI) contrast agents (CAs). Adaptive MRI CAs could improve the accuracy of tumor diagnosis because they realize rapid imaging signal conversion under an endogenous stimulus. Herein, based on the hydrophilic to hydrophobic transition of polymers, we propose a pH-responsive T1/T2 switchable ESIONP contrast agent. ESIONPs are functionalized at the surface with adamantane groups through a polyethylene glycol (PEG) chain, and subsequently, a stimuli-responsive polymer (PSDM) with pH-dependent solubility is introduced through the host–guest interaction between adamantane and β-cyclodextrin (β-CD). The obtained ESIONPs-PEG-PSDM is equipped with remarkable pH responsiveness, which triggers the aggregation of ESIONPs under the tumor acid condition, leading to the switch from a T1 to a T2 contrast agent. In vivo MRI experiments show that the T2 contrast signal is selectively enhanced at the tumor location after injection of ESIONPs-PEG-PSDM. Therefore, ESIONPs-PEG-PSDM with pH-induced hydrophilic to hydrophobic transition is a potential smart MRI contrast agent for precise tumor diagnosis
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Lanthanide and Transition Metal Complexes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Suzhou Key Laboratory of Functional Molecular Imaging Technology, CAS Key Laboratory of Nano-Bio Interface, Division of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou 215123, China

CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, Strasbourg 67000, France

Funding

China Postdoctoral Science Foundation · Centre National de la Recherche Scientifique · National Natural Science Foundation of China · Natural Science Foundation of Jiangxi Province · Science and Technology Project of Suzhou Province

References (58)

Show source-provided references
1. 10.1002/chem.20180285110.1002/chem.201802851 ↗
2. 10.1021/acsanm.8b0035910.1021/acsanm.8b00359 ↗
3. 10.1016/j.jcis.2021.12.07110.1016/j.jcis.2021.12.071 ↗
4. 10.1021/acsami.6b1421910.1021/acsami.6b14219 ↗
5. 10.1016/j.cej.2019.12247310.1016/j.cej.2019.122473 ↗
6. 10.1039/c3cc44268c10.1039/c3cc44268c ↗
7. 10.1002/adhm.20200109110.1002/adhm.202001091 ↗
8. 10.1002/adhm.20180039110.1002/adhm.201800391 ↗
9. 10.2741/279610.2741/2796 ↗
10. 10.1021/jacs.9b0874410.1021/jacs.9b08744 ↗
11. 10.1002/adma.20170109510.1002/adma.201701095 ↗
12. 10.1016/j.msec.2018.12.14610.1016/j.msec.2018.12.146 ↗
13. 10.1021/acs.nanolett.6b0033110.1021/acs.nanolett.6b00331 ↗
14. 10.1016/j.matdes.2021.10960010.1016/j.matdes.2021.109600 ↗
15. 10.1021/acs.nanolett.8b0441110.1021/acs.nanolett.8b04411 ↗
16. 10.1002/advs.20190180010.1002/advs.201901800 ↗
17. 10.1021/jacs.8b0416910.1021/jacs.8b04169 ↗
18. 10.1021/ja203340u10.1021/ja203340u ↗
19. 10.1039/D0NR04201C10.1039/D0NR04201C ↗
20. 10.1021/acsnano.7b0003810.1021/acsnano.7b00038 ↗
21. 10.1039/C7NR00089H10.1039/C7NR00089H ↗
22. 10.1039/D1TB01018B10.1039/D1TB01018B ↗
23. 10.1021/cr900232t10.1021/cr900232t ↗
24. 10.1016/j.nantod.2020.10102210.1016/j.nantod.2020.101022 ↗
25. 10.1021/acs.bioconjchem.9b0065910.1021/acs.bioconjchem.9b00659 ↗
26. 10.1016/j.msec.2019.01.06610.1016/j.msec.2019.01.066 ↗
27. 10.1039/D0TB02411B10.1039/D0TB02411B ↗
28. 10.1021/acsabm.0c0095810.1021/acsabm.0c00958 ↗
29. 10.1021/jacs.0c1024510.1021/jacs.0c10245 ↗
30. 10.1016/j.addr.2012.09.01310.1016/j.addr.2012.09.013 ↗
31. 10.1021/acsami.6b0200610.1021/acsami.6b02006 ↗
32. 10.1021/bm201693j10.1021/bm201693j ↗
33. 10.1002/smll.20090231710.1002/smll.200902317 ↗
34. 10.1021/acsami.1c2041610.1021/acsami.1c20416 ↗
35. 10.1016/j.pmatsci.2020.10066610.1016/j.pmatsci.2020.100666 ↗
36. 10.1039/D1TB01629F10.1039/D1TB01629F ↗
37. 10.1016/j.cej.2018.09.13910.1016/j.cej.2018.09.139 ↗
38. 10.1039/c3cs60048c10.1039/c3cs60048c ↗
39. 10.1016/j.jconrel.2016.07.02410.1016/j.jconrel.2016.07.024 ↗
40. 10.1021/acs.macromol.5b0145310.1021/acs.macromol.5b01453 ↗
41. 10.1016/j.jconrel.2013.08.00710.1016/j.jconrel.2013.08.007 ↗
42. 10.1016/j.reactfunctpolym.2017.09.00310.1016/j.reactfunctpolym.2017.09.003 ↗
43. 10.1002/jbm.a.3635610.1002/jbm.a.36356 ↗
44. 10.1039/C1PY00478F10.1039/C1PY00478F ↗
45. 10.1021/ma102196q10.1021/ma102196q ↗
46. 10.1021/ma400352m10.1021/ma400352m ↗
47. 10.1039/C9SM00978G10.1039/C9SM00978G ↗
48. 10.1016/j.reactfunctpolym.2017.09.00310.1016/j.reactfunctpolym.2017.09.003 ↗
49. 10.1021/acsnano.8b0298010.1021/acsnano.8b02980 ↗
50. 10.1016/j.actbio.2016.05.01810.1016/j.actbio.2016.05.018 ↗
51. 10.1002/adfm.20110176610.1002/adfm.201101766 ↗
52. 10.1002/ppsc.20150025110.1002/ppsc.201500251 ↗
53. 10.1016/j.biomaterials.2016.02.00210.1016/j.biomaterials.2016.02.002 ↗
54. 10.1063/1.475144210.1063/1.4751442 ↗
55. 10.1002/adhm.20120007810.1002/adhm.201200078 ↗
56. 10.1039/C5CS00541H10.1039/C5CS00541H ↗
57. 10.1016/S0168-3659(02)00021-410.1016/S0168-3659(02)00021-4 ↗
58. 10.1021/ma002194910.1021/ma0021949 ↗